Evidence map›Paper›PMID 28323992›Full record

ArticleThe Journal of clinical endocrinology and metabolism2017

Quantification of Thyroid Cancer and Multinodular Goiter Risk in the DICER1 Syndrome: A Family-Based Cohort Study.

Nicholas E Khan, Andrew J Bauer, Kris Ann P Schultz, Leslie Doros, Rosamma M Decastro, Alexander Ling, Maya B Lodish, Laura A Harney, Ron G Kase, Ann G Carr and 8 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00565903 (Elucidating the Genetic Basis of the Pleuropulmonary Blastoma), which is not on this map. Cited by 86 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 3 pooled it
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00565903 completednot on this map

Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome

TypeobservationalSponsorAshley HillRan2005 to 2022Enrolled1,247ConditionsPleuropulmonary Blastoma, Cystic Nephroma, Sertoli-Leydig Cell Tumor of Ovary, Medulloepithelioma
3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 3 syntheses or guidelines pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Expanding the Molecular Data ofHuman mutation · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Germline Variants in Pediatric Cancer : Based on Oncogenic Pathways.Journal of Korean Neurosurgical Society · 2025
    Article
  19. Prognostic Significance of GermlineJCO precision oncology · 2025
    Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 1 country.

Nicholas E KhanClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850.
Andrew J BauerThe Thyroid Center, Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104.
Kris Ann P SchultzCancer and Blood Disorders, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota 55404.
Leslie DorosFood and Drug Administration, Silver Spring, Maryland 20993.
Rosamma M DecastroClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850.
Alexander LingRadiology & Imaging Sciences Department, Clinical Center, National Institutes of Health, Bethesda, Maryland 20892.
Maya B LodishSection of Endocrinology and Genetics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892.
Laura A HarneyWestat, Inc., Rockville, Maryland 20850.
Ron G KaseWestat, Inc., Rockville, Maryland 20850.
Ann G CarrWestat, Inc., Rockville, Maryland 20850.
Christopher T RossiDivision of Pathology and Center for Genetic Medicine Research, Children's National Health System, Washington, DC 20010.
Amanda FieldDivision of Pathology and Center for Genetic Medicine Research, Children's National Health System, Washington, DC 20010.
Anne K HarrisCancer and Blood Disorders, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota 55404.
Gretchen M WilliamsCancer and Blood Disorders, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota 55404.
Louis P DehnerWashington University in St. Louis, St. Louis, Missouri 63130.
Yoav H MessingerCancer and Blood Disorders, Children's Hospitals and Clinics of Minnesota, Minneapolis, Minnesota 55404.
D Ashley HillDivision of Pathology and Center for Genetic Medicine Research, Children's National Health System, Washington, DC 20010.
Douglas R StewartClinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland 20850.
Children’s Minnesota - St. Paul Hospital · USNational Cancer Institute · USWestat (United States) · USChildren's National · USChildren's Hospital of Philadelphia · USGeorge Washington University · USNational Institutes of Health · USNational Institutes of Health Clinical Center · USUnited States Food and Drug Administration · USWashington University in St. Louis · US

Funding

Clinical Genetic Studies of Familial and Hereditary Cancer SyndromesZIACP010144 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI SAVAGE, SHARON A. · 2009 to 2025
$111.8M
DICER1 and the Pleuropulmonary Blastoma Family Cancer SyndromeR01CA143167 · NCI · CHILDREN'S RESEARCH INSTITUTE · PI HILL, DANA ASHLEY · 2010 to 2020
$3.7M
NCI NIH HHS R01 CA143167
6 · The paper itself

Abstract

Context: The risk of thyroid cancer and multinodular goiter (MNG) in DICER1 syndrome, a rare tumor-predisposition disorder, is unknown. Objective: To quantify the risk of thyroid cancer and MNG in individuals with DICER1 syndrome. Design: Family-based cohort study. Setting: National Institutes of Health (NIH) Clinical Center (CC). Participants: The National Cancer Institute DICER1 syndrome cohort included 145 individuals with a DICER1 germline mutation and 135 family controls from 48 families. Interventions: Each individual completed a detailed medical history questionnaire. A subset underwent a 3-day evaluation at the NIH CC. Main Outcome Measures: The cumulative incidence of MNG (or thyroidectomy) was quantified using the complement of the Kaplan-Meier product limit estimator. We compared the observed number of thyroid cancers in the NCI DICER1 cohort with matched data from the Surveillance, Epidemiology, and End Results (SEER) Program. We performed germline and somatic (thyroid cancer, MNG) DICER1 sequencing. Results: By the age of 40 years, the cumulative incidence of MNG or thyroidectomy was 75% in women and 17% in men with DICER1 syndrome compared with 8% of control women (P < 0.001) and 0% of control men (P = 0.0096). During 3937 person-years of observation, individuals with DICER1 syndrome had a 16-fold increased risk of thyroid cancer (95% confidence interval, 4.3 to 41; P < 0.05) compared with the SEER rates. Of 19 MNG nodules and 3 thyroid cancers, 16 (84%) and 3 (100%), respectively, harbored germline and somatic pathogenic DICER1 mutations. Conclusions: We propose a model of thyroid carcinogenesis in DICER1 syndrome. Early-onset, familial, or male MNG should prompt consideration of the presence of DICER1 syndrome.

Indexed as

Adenocarcinoma, FollicularAdolescentAdultCarcinomaCarcinoma, PapillaryCase-Control StudiesCohort StudiesDEAD-box RNA HelicasesFamilyFemaleGerm-Line MutationGoiter, NodularHumansIncidenceMaleNeoplastic Syndromes, HereditaryDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease III

Identifiers

PMID28323992
PMCPMC5443331
OpenAlexW2610547404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.